cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.25934/00002628
title: A Phase 1, Single-Blind, Placebo-Controlled, Randomized, Parallel-Design Study to Evaluate the Possible Effects of Age, Gender, and Race on the Safety and Pharmacokinetics of Single and Multiple Doses of TAK-491 in Healthy Adult Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002626
title: A Phase 1, Single-Dose, Double-Blind, Sequential-Panel, Randomized, Placebo-Controlled, Dose-Escalation Study to Examine the Safety, Tolerability, and Pharmacokinetics of TAK-491 in Healthy Male Volunteers

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002625
title: An Open-Label Study to Assess the Drug-Drug Interaction Between Ramelteon and Doxepin in Normal Healthy Male and Female Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002624
title: An Open-Label Study to Assess the Drug-Drug Interaction Between Ramelteon and Donepezil in Normal Healthy Male and Female Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002623
title: An Open-Label Study to Assess the Drug-Drug Interaction Between Ramelteon and Gabapentin in Normal Healthy Male and Female Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00003325
title: An Open Label, Randomized, Crossover Study to Determine the Effect of Food on the Pharmacokinetics of TAK-536 in Healty Male and Female Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002622
title: A Phase 1, Open-Label, Randomized, Multiple-Dose, Crossover Study to Assess the Drug-Drug Interaction of TAK-536 and Pioglitazone HCl

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002621
title: The Effect of Multiple Doses of Fluconazole or Ketoconazole on the Single-Dose Pharmacokinetic Profile of TAK-536 in Healthy Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002620
title: An Open-Label, Multiple-Dose Study to Assess the Drug Drug Interaction Between TAK-536 and Midazolam, Caffeine, Tolbutamide, Dextromethorphan, and Fexofenadine in Healthy Male and Female Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002619
title: An Open-Label Study to Assess the Drug-Drug Interaction Between Ramelteon and Escitalopram in Normal Healthy Male and Female Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002616
title: An Open-Label Study to Assess the Drug-Drug Interaction Between Ramelteon and Fluvoxamine in Normal Healthy Male and Female Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002615
title: A Double-Blind, Randomized, 4-Period Crossover Study to Assess the Pharmacodynamic Interaction Between Ramelteon (TAK-375) 32 mg and Ethanol 0.6 g/kg in Healthy Adult Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002614
title: A Randomized, Single-Blind, Crossover, Phase I Evaluation of the Effect of TAK-375 on the QT Interval in Healthy Adult Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002613
title: Phase I, Open Label, Randomized, Multiple-Dose, Two Period Cross-Over, Single-Center Study to Assess the Effect of TAK-375 on the Pharmacokinetics of Digoxin in Healthy Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002611
title: Phase I, Multiple Dose, Open-Label, Single-Center Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of TAK-375

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002610
title: An Open-Label, Multiple Dose, Drug Interaction Study of the Effects of Fluoxetine on the Pharmacokinetics of TAK 375 in Normal Healthy Male and Female Adult Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.5284/1124464
title: Images from a Historic Building Recording Survey and Heritage Impact Assesment at Bridge at Perran Wharf, Perranarworthal, Cornwall, January 2024

description: This digital archive comprises images from a historic building record survey and heritage impact assessment prior to the repair of a Grade II Listed road bridge (List Entry Number: 1328631).The work was undertaken on the 9th January 2024, by Cornwall Archaeological unit, commissioned on behalf of Cormac Solutions Ltd. The bridge is located immediately northeast of Perran Wharf in Perranarworthal at NGR SW 77755 38542. The bridge was first built here in the mid 19th century (at some point between c1840 and c1880), probably in the late 1850s when the Williams family undertook major remodelling of Perran Foundry and redirected the road which had previously run through centre of the foundry to the north. Since its construction the bridge has only seen fairly minor alterations.
DOI: 10.25934/00002609
title: An Open-Label Assessment of the Pharmacokinetics and Pharmacodynamics of Warfarin in the Presence
of Multiple Doses of TAK-375 in Healthy Female and Male Adult Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002608
title: A Phase I, Randomized, Double-Blind, Placebo Controlled, Parallel, Multi-Center, Safety Study to Evaluate the Short-Term Effects of TAK-375 on Endocrine Function in Healthy Adult Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002607
title: Evaluation of the Single and Multiple Dose Pharmacokinetics of TAK-375 in Subjects With and Without Renal Impairment

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002606
title: Clinical Protocol for a TAK-375 Single and Multiple Dose Pharmacokinetic Evaluation in Subjects With and Without Hepatic Impairment

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002605
title: A Double-Blind, Randomized, Four-Period Crossover Study to Assess the Pharmacodynamic Drug-Drug Interaction Between TAK-375 and Ethanol in Healthy Adult Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.48597/v5wv-pvyn
title: Measurement of PM mass at Rucava

description: Measurement of PM mass at Rucava
DOI: 10.25934/00002603
title: An Open Label, Randomized, Three Period Crossover Study to Assess the Drug-Drug Interaction Between TAK-375 and Dextromethorphan in Healthy Female and Male Adult Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002604
title: An Open Label, Multiple Dose, Randomized, Two Period Crossover Study to Assess the Drug-Drug Interaction Between TAK-375 and Theophylline in Healthy Female and Male Adult Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.48597/97cs-745r
title: Measurement of PM mass at Rucava

description: Measurement of PM mass at Rucava
DOI: 10.25934/00002600
title: An Open-Label, Crossover, Drug Interation Study of the Effects of Fluconazole on the Single-Dose Pharmacokinetics of TAK-375 in Normal Healthy Male and Female Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.48597/9w62-7y64
title: Measurement of PM mass at Rucava

description: Measurement of PM mass at Rucava
DOI: 10.25934/00002598
title: An Open-Label, Crossover, Drug Interaction Study of the Effects of Ketoconazole on the Pharmacokinetics of TAK-375 in Normal, Healthy Male and Female Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002597
title: A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Four-Period Crossover Evaluation of the Circadian Phase-Shifting Effects of TAK-375 in Normal Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002595
title: Effect of Food on the Pharmacokinetics of TAK-375 in Healthy Male and Female Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002589
title: Cultural adaptation and validation of "COPD Assessment Test" (CAT) into Spanish

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002592
title: Evaluation of the Quality of Life in COPD patients in Europe



description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002593
title: COPD prevalence estimation in Spanish population.

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.5281/zenodo.12744254
title: CS_2007_16s_bioinf_outputs

description: Bioinformatic outputs for CS 2007 16S (bacterial) data.

Sample ID's within otu table cross reference with "Plot" column in  Soil physico-chemical properties 2007 [Countryside Survey] - EIDC (ceh.ac.uk).
DOI: 10.5281/zenodo.12744255
title: CS_2007_16s_bioinf_outputs

description: Bioinformatic outputs for CS 2007 16S (bacterial) data.

Sample ID's within otu table cross reference with "Plot" column in  Soil physico-chemical properties 2007 [Countryside Survey] - EIDC (ceh.ac.uk).
DOI: 10.25934/00004025
title: A multicenter Phase I open-label dose-escalation vaccine trial of dHER2 prot. with AS15 adj. in HER2-overexpressing patients with high-risk breast cancer {NCT00058526 }


description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006578
title: An Open-Label, Randomized, Two-Period, Crossover Study to Evaluate
the Relative Bioavailability of an Immediate Release Test Tablet
Formulation of Oxycodone Hydrochloride (15 mg) Compared to an
Equivalent Dose of a Commercially Available Reference Drug Product
(Roxicodone™ 15 mg Tablet, Roxane Laboratories Inc.) in Normal Human
Subjects Under Fasting Conditions

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.